Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2839540 | Clínica e Investigación en Arteriosclerosis | 2015 | 5 Pages |
Abstract
Survivors of cancer have a shorter survival in the long term partly due to the increase in cardiovascular diseases (CVD). Some chemotherapy drugs, thoracic and cranial radiotherapy and above all the transplantation of hematopoietic cells are associated with an increase in the incidence of cardiovascular events compared with general population. Some of these treatments favor the development of a metabolic syndrome that could be the intermediary between these treatments and the development of CVD. It is recommended for cancer survivors to promote healthy lifestyles and the strict control of cardiovascular risk factors.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Physiology
Authors
Carlos Lahoz, Pedro Valdivielso, MarÃa Teresa González-Alegre, MarÃa Francisca GarcÃa-Iglesias, Eva Estirado, José M. Mostaza,